Nefazodone Treatment of Adolescent Depression: An Open-Label Study of Response and Biochemistry

By Goodnick P.J.   Jorge C.A.   Hunter T.   Kumar A.M.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 12, Iss. 2, 2000-06 ,pp. : 97-100

Springer Publishing Company

Access to resources Recommend Favorite

Olanzapine in the treatment of depression with psychotic features: A prospective open-label study

By Adli Mazda   Wiethoff Katja   Baethge Christopher   Pfennig Andrea   Stamm Thomas   Bauer Michael  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 3, 2008-01 ,pp. : 202-209

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Designing and implementing a primary care intervention trial to improve the quality and outcome of care for major depression

By Rost K.   Nutting P.A.   Smith J.   Werner J.J.  

General Hospital Psychiatry, Vol. 22, Iss. 2, 2000-04 ,pp. : 66-77

Elsevier

Access to resources Recommend Favorite

The Efficacy and Tolerability of Duloxetine in the Treatment of Anxious Versus Non-Anxious Depression: A Post-Hoc Analysis of an Open-Label Outpatient Study

By Fava Maurizio   Martinez James M.   Greist John   Marangell Lauren B.   Brown Eileen   Chen Lei   Wohlreich Madelaine M.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 19, Iss. 3, 2007-07 ,pp. : 187-195

Informa Healthcare

Access to resources Recommend Favorite

The KEEPER&unknown; trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study

By Morrell M.J.   Leppik I.   French J.   Ferrendelli J.   Han J.   Magnus L.  

Epilepsy Research, Vol. 54, Iss. 2, 2003-05 ,pp. : 153-161

Elsevier

Access to resources Recommend Favorite